This case report underscores the complexities and challenges of treating poorly differentiated lung carcinoma with the BRAF K601E mutation, highlighting the nuanced nature of cancer therapies, particularly in cases involving less common mutations. The gene discussed is BRAF; the disease is lung carcinoma.